Pre-order Enquiry
Request Free Sample
Global Bispecific Antibody Therapeutic Market Insights and Forecast to 2027
SKU ID : QYR-18162781 | Publishing Date : 03-May-2021 | No. of pages : 113
Request Sample
Request Customization
Check Discounts
Bispecific antibodies (BsAbs) recognize two different epitopes. This dual specificity opens up a wide range of applications, including redirecting T cells to tumor cells, blocking two different signaling pathways simultaneously, dual targeting of different disease mediators, and delivering payloads to targeted sites. The approval of catumaxomab (anti-EpCAM and anti-CD3) and blinatumomab (anti-CD19 and anti-CD3) has become a major milestone in the development of bsAbs. Currently, more than 60 different bsAb formats exist, some of them making their way into the clinical pipeline. This review summarizes diverse formats of bsAbs and their clinical applications and sheds light on strategies to optimize the design of bsAbs.
Market Analysis and Insights: Global Bispecific Antibody Therapeutic Market
The global Bispecific Antibody Therapeutic market is valued at US$ XX million in 2019. The market size will reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.
Global Bispecific Antibody Therapeutic Scope and Segment
Bispecific Antibody Therapeutic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bispecific Antibody Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
Bearing An Fc Region
Lacking An Fc Region
Segment by Application
Osteology
Pulmonary
Respiratory Diseases
Oncology
Gene Therapy
By Company
Creative-biolabs
PharmAbcine
Sorrento Therapeutics
Patheon
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Market Analysis and Insights: Global Bispecific Antibody Therapeutic Market
The global Bispecific Antibody Therapeutic market is valued at US$ XX million in 2019. The market size will reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.
Global Bispecific Antibody Therapeutic Scope and Segment
Bispecific Antibody Therapeutic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bispecific Antibody Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
Bearing An Fc Region
Lacking An Fc Region
Segment by Application
Osteology
Pulmonary
Respiratory Diseases
Oncology
Gene Therapy
By Company
Creative-biolabs
PharmAbcine
Sorrento Therapeutics
Patheon
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
